Combination products like multi-drug pills, inhalers, and topical creams face unique bioequivalence challenges that delay generic access. Learn why testing them is harder, costlier, and more complex than single-drug generics.
Details
Generic combinations are transforming the pharmaceutical industry by offering smarter, more effective alternatives to branded drugs at lower costs. With growing regulatory support and rising demand, they’re becoming the future of affordable healthcare.
Details